About Pregenen
Pregenen is a company based in Seattle (United States) founded in 2006, and was acquired by Bluebird Bio in June 2014. Limited information available.
Company details
Pregenen, established in 2006 and currently in Acquired stage, focuses on limited information available. Limited information available. Adapting to market demands with innovation. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
- Headquarters Seattle, United States
- Stage Acquired
- Website pregenen.com
- Acquired by Bluebird Bio (Jun 2014)
- Investors
- Acquired byBluebird Bio
(Jun 2014)
Investors in Pregenen
Pregenen has secured backing from 1 investor. Prominent investors backing the company include Bluebird Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Gene therapies for severe genetic and rare diseases are developed. | 1992 | bluebirdbio.com | Cambridge, United States |
Investor details for Pregenen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Pregenen
2 dated milestones of Pregenen across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Pregenen is founded.
- Exit Acquired by Bluebird Bio.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pregenen
Pregenen was founded in 2006.
Pregenen is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Pregenen, established in 2006 and currently in Acquired stage, focuses on limited information available. Limited information available. Adapting to market demands with innovation. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
Pregenen has 1 investor. Key investors include Bluebird Bio.
Yes. Pregenen was acquired by Bluebird Bio in June 2014.